NEUE director rolls shares into NH Holdings units after 10/02/2025 merger
Rhea-AI Filing Summary
Matthew G. Manders, a director of NeueHealth, Inc. (NEUE), reported a transaction dated 10/02/2025 that reduced his direct beneficial ownership of the company's common stock to 0 shares. The filing states that NH Holdings 2025, Inc. completed a merger that made the issuer a wholly owned subsidiary of Parent, and that the Reporting Person contributed his common stock and Series A and Series B preferred shares to NH Holdings 2025 SPV, L.P. under a Rollover Agreement, receiving Holdings units on a one-for-one basis effective at the merger closing. The Form 4 is signed by an attorney-in-fact on 10/06/2025.
Positive
- Director retained economic exposure by receiving Holdings common units and preferred units on a one-for-one basis under the Rollover Agreement
- Merger completion converted the issuer into a wholly-owned subsidiary, clarifying corporate control by NH Holdings 2025, Inc.
Negative
- Direct public ownership reduced to 0 shares following the reported disposition of 16,741 common shares
- Public disclosure of direct insider holdings ended, potentially reducing transparency for investors tracking director-level ownership
Insights
Director moved from direct equity to rollover units at merger close.
The filing documents a corporate control transaction where NEUE merged into a subsidiary of NH Holdings 2025, Inc., and the director's equity holdings were contributed to the sponsor vehicle under a Rollover Agreement. This changes the director's holding form from direct common stock and preferred shares to private-equity-held units.
This structure preserves economic exposure but removes public direct ownership; governance rights and transfer restrictions may differ and will depend on the Holdings' unit agreements. Monitor any subsequent disclosure about voting arrangements or lock-ups within the next 12 months.
Merger closed on 10/02/2025; insider reported disposition of 16,741 shares.
The Form 4 shows a reported disposition code tied to the Merger and an explicit statement that the Issuer became a wholly-owned subsidiary of Parent controlled by funds affiliated with New Enterprise Associates, Inc. The Reporting Person received Holdings common units and preferred units on a one-for-one basis per the Rollover Agreement dated 08/14/2025.
Key near-term items to watch are any Schedule 13D/G updates or disclosures from the sponsor about future liquidity events or timelines for converting or cashing out the rollover units within 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Common Stock | 16,741 | $0.00 | -- |
Footnotes (1)
- On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. Pursuant to the Rollover Agreement, dated as of August 14, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time").
